JNJ-55308942
N/A
Report date: 2026/02/04 12:02:22
NME
Base Information
Drug NameJNJ-55308942
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Innovative MedicineJohnson & Johnson
China Registration ClassN/A
Develop Information
Active CompaniesJanssen Pharmaceutical Nv
Inactive CompaniesJanssen-Cilag International Nv
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A